Media Pack
News

Current Edition

Volume 16 Issue 1
 
Regional News

Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines

In the past few weeks, anti-vaxxers have rallied behind a nonpeer-reviewed study by a group of Canadian researchers as evidence against COVID-19 vaccines. Turns out, ...
6 October 2021 Regional News COVID-19 | heart inflammation
Continue Reading →
Regional News

FDA’s Marks takes over vaccines office as agency prepares to part ways with 2 key officials

Amid the heated debate over COVID-19 booster shots, two key FDA vaccine experts said they'd be leaving the agency last month. In an effort to smooth over the transiti...
29 September 2021 Regional News booster shots | Center for Biologics Evaluation and Research
Continue Reading →
Regional News

Pfizer plans to seek FDA nod for COVID-19 shot in kids 5 to 11 after positive data

With coronavirus cases on the rise among children, Pfizer and BioNTech brought welcome news on Monday, reporting their COVID-19 vaccine is safe and generated a strong...
22 September 2021 Regional News COVID-19 | FDA
Continue Reading →
Regional News

Amid COVID’s latest surge, Regeneron and Eli Lilly score new antibody supply deals with the U.S.

During a call with analysts last month, Regeneron said it didn’t expect to record additional sales of its COVID-19 antibodies to the United States this year. But les...
16 September 2021 Regional News antibody | COVID
Continue Reading →
Regional News

Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it’s not contamination

In recent weeks, Moderna has had to deal with reports of contaminants discovered in vials of its COVID-19 vaccine in Japan. Now it’s Pfizer doing the same after whit...
16 September 2021 Regional News COVID-19 | Japan
Continue Reading →
Regional News

AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battle

At times during the pandemic, there’s been no love lost between AstraZeneca and the EU. After the U.K. pharma giant fell behind on its planned COVID-19 vaccine deliv...
8 September 2021 Regional News AstraZeneca | COVID-19
Continue Reading →
Regional News

After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines

As Moderna faces questions about contaminants found in its COVID-19 vaccines in Japan, the company’s distribution partner in the country, Takeda, is moving forward on...
8 September 2021 Regional News COVID-19 | Japan
Continue Reading →
Regional News

Key vaccine leaders departing FDA as COVID-19 booster questions linger

Two key vaccine leaders will leave the FDA this fall, just as the agency faces key decisions over COVID-19 booster shots and as variants take a bite out of the shots’...
1 September 2021 Regional News booster | COVID-19
Continue Reading →
Regional News

FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris Poll

Last week's FDA approval of Pfizer’s Comirnaty vaccine boosted consumer confidence among both vaccinated and unvaccinated people. A Harris Poll survey over the weeke...
1 September 2021 Regional News COVID-19 | FDA
Continue Reading →
Regional News

Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health quests

Eli Lilly’s Olympic sponsorship ended last week with millions of media impressions, bolstered corporate pride and even a gold medal for one of its athletes. Volleybal...
18 August 2021 Regional News COVID-19 | Eli Lilly
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte